News

Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has agreed in principle to supply the Government of Canada with doses of its SARS-CoV-2 vaccine candidate, Ad26.COV2.S. The availability of the vaccine candidate is subject to...

Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in Lenexa, Kansas dedicated to viral transport media (VTM) production. The company is also announcing that the site will...

CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has once again expanded their global reach and local presence with the opening of a new hub operation in Taipei, Taiwan. This new addition to...

Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider of lab testing and expert advisory services signed  a partnership agreement that will provide...

AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin. SCLC is a highly...

AstraZeneca has expanded the clinical development of its potential Covid-19 vaccine candidate AZD1222 in the US, by initiating a Phase 3 clinical trial, dubbed D8110C00001. The late-stage clinical trial is aimed at evaluating the safety, efficacy and immunogenicity of the...

Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely or critically illb patients hospitalized with COVID-19 did not meet its primary endpoint and key...